-
Je něco špatně v tomto záznamu ?
Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain
R. Hexnerová, K. Křížková, M. Fábry, I. Sieglová, K. Kedrová, M. Collinsová, P. Ullrichová, P. Srb, C. Williams, MP. Crump, Z. Tošner, J. Jiráček, V. Veverka, L. Žáková,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2008 do Před 1 rokem
Freely Accessible Science Journals
od 1905 do Před 1 rokem
PubMed Central
od 2005
Europe PubMed Central
od 2005 do Před 1 rokem
Open Access Digital Library
od 1905-10-01
Open Access Digital Library
od 1905-10-01
ROAD: Directory of Open Access Scholarly Resources
od 1905
PubMed
27510031
DOI
10.1074/jbc.m116.741041
Knihovny.cz E-zdroje
- MeSH
- CD antigeny chemie genetika metabolismus MeSH
- insulinu podobný růstový faktor II chemie genetika metabolismus MeSH
- lidé MeSH
- missense mutace MeSH
- protein - isoformy chemie genetika metabolismus MeSH
- proteinové domény MeSH
- receptor IGF typ 1 chemie genetika metabolismus MeSH
- receptor inzulinu chemie genetika metabolismus MeSH
- rekombinantní proteiny chemie genetika metabolismus MeSH
- substituce aminokyselin MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF-1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailed NMR structural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023785
- 003
- CZ-PrNML
- 005
- 20170720122335.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1074/jbc.M116.741041 $2 doi
- 035 __
- $a (PubMed)27510031
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hexnerová, Rozálie $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
- 245 10
- $a Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain / $c R. Hexnerová, K. Křížková, M. Fábry, I. Sieglová, K. Kedrová, M. Collinsová, P. Ullrichová, P. Srb, C. Williams, MP. Crump, Z. Tošner, J. Jiráček, V. Veverka, L. Žáková,
- 520 9_
- $a Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF-1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailed NMR structural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a CD antigeny $x chemie $x genetika $x metabolismus $7 D015703
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a insulinu podobný růstový faktor II $x chemie $x genetika $x metabolismus $7 D007335
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a protein - isoformy $x chemie $x genetika $x metabolismus $7 D020033
- 650 _2
- $a receptor IGF typ 1 $x chemie $x genetika $x metabolismus $7 D017526
- 650 _2
- $a receptor inzulinu $x chemie $x genetika $x metabolismus $7 D011972
- 650 _2
- $a rekombinantní proteiny $x chemie $x genetika $x metabolismus $7 D011994
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Křížková, Květoslava $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
- 700 1_
- $a Fábry, Milan $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic, and.
- 700 1_
- $a Sieglová, Irena $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Kedrová, Kateřina $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
- 700 1_
- $a Collinsová, Michaela $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Ullrichová, Pavlína $u Department of Analytical Chemistry, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Srb, Pavel $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Williams, Christopher $u Department of Organic and Biological Chemistry, School of Chemistry, Cantock's Close, University of Bristol, Bristol BS8 1TS, United Kingdom.
- 700 1_
- $a Crump, Matthew P $u Department of Organic and Biological Chemistry, School of Chemistry, Cantock's Close, University of Bristol, Bristol BS8 1TS, United Kingdom.
- 700 1_
- $a Tošner, Zdeněk $u Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
- 700 1_
- $a Jiráček, Jiří $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Veverka, Václav $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, vaclav.veverka@uochb.cas.cz.
- 700 1_
- $a Žáková, Lenka $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, zakova@uochb.cas.cz.
- 773 0_
- $w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 291, č. 40 (2016), s. 21234-21245
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27510031 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720122828 $b ABA008
- 999 __
- $a ok $b bmc $g 1239466 $s 984698
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 291 $c 40 $d 21234-21245 $e 20160810 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
- LZP __
- $a Pubmed-20170720